Drugs / Nimesulide
Nimesulide
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT01500577 | Apr 2005 → Nov 2012 | breast cancer | European Institute of Oncology | Completed | No outcome recorded |
| Phase 31 trial · 1 met primary | ||||||
| Phase 3 | NCT01670552 | Feb → Oct 2016 | dyspepsia | EMS | Completed | Met primary |
| Phase not applicable1 trial | ||||||
| — | NCT03400462 | Jul 2016 → Nov 2017 | temporomandibular joint disorder | Pomeranian Medical University Szczecin | Completed | No outcome recorded |
| Comparator or background therapy4 trials | ||||||
| Phase 2 | NCT04609748 Comparator | Jan → Jul 2021 | temporomandibular joint dysfunction syndrome | Pomeranian Medical University Szczecin | Unknown | No outcome recorded |
| Phase 4 | NCT01257126 Comparator | Apr → Dec 2011 | respiratory tract infectious disorder | Novartis Pharmaceuticals | Withdrawn | No outcome recorded |
| Phase 4 | NCT02229747 Comparator | Aug 2001 → Feb 2002 | pharyngitis | Boehringer Ingelheim | Completed | No outcome recorded |
| — | NCT03119324 Comparator | Sep 2015 → Jun 2016 | temporomandibular joint disorder | University of Roma La Sapienza | Completed | No outcome recorded |
Press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2024-05-27 | Helsinn Healthcare SA | Helsinn and Angelini Pharma sign a partnership agreement renewal to commercialize AULIN® and MESULID® in Bulgaria, Czech Republic, Hungary, Poland, Romania and Slovak Republic helsinn.com ↗ |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nimesulide | “Nimesulide has anti-inflammatory and analgesic properties.” NCT03400462 ↗ |
| Known as | Aulin | ChEMBL registry synonym — accepted as the source's own label CHEMBL56367 ↗ |
| Known as | Nimesulida | ChEMBL registry synonym — accepted as the source's own label CHEMBL56367 ↗ |
| Known as | Nimesulide Ratiopharm | “Non Steroidal Anti Inflammatory drug, Nimesulide Ratiopharm® (100 mg a day)” NCT03119324 ↗ |
| Known as | NSC-758412 | ChEMBL registry synonym — accepted as the source's own label CHEMBL56367 ↗ |
| Known as | R 805 | ChEMBL registry synonym — accepted as the source's own label CHEMBL56367 ↗ |
| Action | Inhibit | “it inhibits the action of COX” NCT03400462 ↗ |
| Modality | Small molecule | — CHEMBL56367 ↗ |
| Route | Oral | “applied orally” NCT04609748 ↗ |